Literature DB >> 15351438

APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: implications for Alzheimer's disease.

Hafiz Mohmmad Abdul1, Gary L Wenk, McGann Gramling, Beatrice Hauss-Wegrzyniak, D Allan Butterfield.   

Abstract

Epidemiological and biochemical studies strongly implicate a role for cholesterol in the pathogenesis of Alzheimer's disease (AD). Mutation in the PS-1 and APP genes, which increases production of the highly amyloidogenic amyloid beta-peptide (Abeta42), is the major cause of familial AD. The AD brain is under significant oxidative stress, including protein oxidation and lipid peroxidation. In the present study, protein oxidation and lipid peroxidation were compared in the brain homogenates from knock-in mice expressing mutant human PS-1 and APP in relation to the intake of dietary cholesterol. The APP and PS-1 mice displayed increased oxidative stress as measured by protein oxidation and lipid peroxidation, independent of dietary cholesterol. These results are discussed with reference to proposed therapeutic strategies of AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15351438     DOI: 10.1016/j.neulet.2004.06.077

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  18 in total

Review 1.  Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.

Authors:  Meaghan C Creed; Norton W Milgram
Journal:  Age (Dordr)       Date:  2010-04-20

Review 2.  Redox proteomics in some age-related neurodegenerative disorders or models thereof.

Authors:  D Allan Butterfield; Hafiz Mohmmad Abdul; Shelley Newman; Tanea Reed
Journal:  NeuroRx       Date:  2006-07

3.  Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor protein.

Authors:  R A S Robinson; M B Lange; R Sultana; V Galvan; J Fombonne; O Gorostiza; J Zhang; G Warrier; J Cai; W M Pierce; D E Bredesen; D A Butterfield
Journal:  Neuroscience       Date:  2011-01-09       Impact factor: 3.590

Review 4.  Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.

Authors:  Rukhsana Sultana; Marzia Perluigi; D Allan Butterfield
Journal:  Acta Neuropathol       Date:  2009-03-14       Impact factor: 17.088

5.  Antioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice.

Authors:  F E Harrison; J Allard; R Bixler; C Usoh; L Li; J M May; M P McDonald
Journal:  Nutr Neurosci       Date:  2009-10       Impact factor: 4.994

6.  Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age.

Authors:  Hafiz Mohmmad Abdul; Rukhsana Sultana; Daret K St Clair; William R Markesbery; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2008-08-16       Impact factor: 7.376

Review 7.  Presenilin transgenic mice as models of Alzheimer's disease.

Authors:  Gregory A Elder; Miguel A Gama Sosa; Rita De Gasperi; Dara L Dickstein; Patrick R Hof
Journal:  Brain Struct Funct       Date:  2009-11-18       Impact factor: 3.270

8.  A new chiral pyrrolyl α-nitronyl nitroxide radical attenuates β-amyloid deposition and rescues memory deficits in a mouse model of Alzheimer disease.

Authors:  Tian-Yao Shi; Da-Qing Zhao; Hai-Bo Wang; Shufang Feng; Shui-Bing Liu; Jiang-Hao Xing; Yang Qu; Peng Gao; Xiao-Li Sun; Ming-Gao Zhao
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

Review 9.  Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models.

Authors:  Joshua A Sonnen; John C Breitner; Mark A Lovell; William R Markesbery; Joseph F Quinn; Thomas J Montine
Journal:  Free Radic Biol Med       Date:  2008-04-24       Impact factor: 7.376

Review 10.  Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment.

Authors:  D Allan Butterfield; Tanea Reed; Shelley F Newman; Rukhsana Sultana
Journal:  Free Radic Biol Med       Date:  2007-06-13       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.